tm
Seeing Is Believing
tm
Seeing Is Believing
Indaptus Therapeutics's activity chart (see below) currently has 5 price targets and 14 ratings on display.
Analysts average stock forecasts to be materialized ratio is 86.67% with an average time for these price targets to be met of 494.6 days.
Most recent stock forecast was given by from MAXIM GROUP on 13-Nov-2024. First documented stock forecast 28-Feb-2018.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date of last PT
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy Since 20-Apr-2023
$5
$1.59 (46.63%)
$8
1 years 7 months 26 days ago
(13-Nov-2024)
2/3 (66.67%)
$-27.9 (-84.80%)
444
Buy Since 31-Jan-2022
$12
$8.59 (251.91%)
1 years 8 months 23 days ago
(16-Oct-2024)
2/2 (100%)
$-28.04 (-70.03%)
680
Buy Since 28-Feb-2018
$364
$362.3 (21311.76%)
$420
5 years 7 months ago
(09-Dec-2020)
2/2 (100%)
$-155.68 (-29.96%)
225
What is INDP (Indaptus Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on INDP (Indaptus Therapeutics) with a proven track record?
Which analyst has the most public recommendations on INDP (Indaptus Therapeutics)?
Which analyst is the currently most bullish on INDP (Indaptus Therapeutics)?
Which analyst is the currently most reserved on INDP (Indaptus Therapeutics)?
